Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 15, keine Gesamtzahl für „study“
Suchtreffer
Begriffe & Kennungen
Blitzima · 4.8 · Table 5 Adverse reactions occurring at 6-months in ≥ 5% of adult patients receiving rituximab in GPA/MPA Study
Eintrag öffnenBlitzima · 4.8 · Table 6 Adverse reactions occurring in ≥ 5% of adult patients receiving rituximab in GPA/MPA Study 2 (Rituixma
Eintrag öffnenBlitzima · 4.8 · Table 7 Adverse reactions in rituximab-treated pemphigus vulgaris patients in PV Study 1 (up to Month 24) and
Eintrag öffnenBlitzima · 4.8 · The adverse reactions from GPA/MPA Study 1 listed in Table 5 with a frequency categorisation of “common” or “v
Eintrag öffnenBlitzima · 4.8 · The most common infusion-related reaction symptoms/Preferred Terms for PV Study 2 were dyspnoea, erythema, hyp
Eintrag öffnenBonviva · 4.5 · H2 blockers or proton pump inhibitors Of over 1500 patients enrolled in study BM 16549 comparing monthly with
Eintrag öffnenBonviva · 4.8 · In a two-year study in postmenopausal women with osteoporosis (BM 16549) the overall safety of Bonviva 150 mg
Eintrag öffnenBonviva · 4.8 · In the pivotal two-year study in postmenopausal women with osteoporosis (BM16550), the overall safety of intra
Eintrag öffnenBortezomib Accord · 4.5 · 12 In a drug-drug interaction study assessing the effect of omeprazole, a potent CYP2C19 inhibitor, on the pha
Eintrag öffnenBortezomib Accord · 4.5 · 45 In a drug-drug interaction study assessing the effect of omeprazole, a potent CYP2C19 inhibitor, on the pha
Eintrag öffnenBortezomib Accord · 4.5 · A drug-drug interaction study assessing the effect of ketoconazole, a potent CYP3A4 inhibitor, on the pharmaco
Eintrag öffnenBortezomib Accord · 4.5 · A drug-drug interaction study assessing the effect of ketoconazole, a potent CYP3A4 inhibitor, on the pharmaco
Eintrag öffnenBortezomib Accord · 4.5 · A drug-drug interaction study assessing the effect of melphalan-prednisone on the pharmacokinetics of bortezom
Eintrag öffnenBortezomib Accord · 4.5 · A drug-drug interaction study assessing the effect of melphalan-prednisone on the pharmacokinetics of bortezom
Eintrag öffnenBortezomib Accord · 4.5 · A drug-drug interaction study assessing the effect of rifampicin, a potent CYP3A4 inducer, on the pharmacokine
Eintrag öffnenBortezomib Accord · 4.5 · A drug-drug interaction study assessing the effect of rifampicin, a potent CYP3A4 inducer, on the pharmacokine
Eintrag öffnenBortezomib Accord · 4.5 · In the same drug-drug interaction study assessing the effect of dexamethasone, a weaker CYP3A4 inducer, on the
Eintrag öffnenBortezomib Accord · 4.5 · In the same drug-drug interaction study assessing the effect of dexamethasone, a weaker CYP3A4 inducer, on the
Eintrag öffnenBortezomib Accord · 4.8 · 21 Retreatment of patients with relapsed multiple myeloma In a study in which bortezomib retreatment was admin
Eintrag öffnenBortezomib Accord · 4.8 · 54 Retreatment of patients with relapsed multiple myeloma In a study in which bortezomib retreatment was admin
Eintrag öffnen